These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1343 related articles for article (PubMed ID: 31060544)

  • 81. Surgical treatment for peritoneal carcinomatosis from gastric cancer.
    Yonemura Y; Endou Y; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Li Y
    Eur J Surg Oncol; 2010 Dec; 36(12):1131-8. PubMed ID: 20933363
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials.
    Green BL; Blumenthaler AN; Gamble LA; McDonald JD; Robinson K; Connolly M; Epstein M; Hernandez JM; Blakely AM; Badgwell BD; Davis JL
    Ann Surg Oncol; 2023 Mar; 30(3):1852-1860. PubMed ID: 36348206
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Morris RS; Gani F; Hammad AY; Peltier W; Gamblin TC; Turaga KK; Johnston FM
    J Surg Res; 2017 May; 211():79-86. PubMed ID: 28501134
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.
    Glehen O; Gilly FN; Arvieux C; Cotte E; Boutitie F; Mansvelt B; Bereder JM; Lorimier G; Quenet F; Elias D;
    Ann Surg Oncol; 2010 Sep; 17(9):2370-7. PubMed ID: 20336386
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
    Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
    Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Elekonawo FMK; Starremans BJ; Kok NFM; Bremers AJA; de Wilt JHW; Aalbers AGJ
    Ann Surg Oncol; 2018 Jul; 25(7):1992-2001. PubMed ID: 29671139
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Regional therapy trials in peritoneal metastases: The path to standardization of care for gastric cancer.
    Badgwell B
    J Surg Oncol; 2022 Jan; 125(1):64-68. PubMed ID: 34897716
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
    Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
    Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    van 't Sant I; van Eden WJ; Engbersen MP; Kok NFM; Woensdregt K; Lambregts DMJ; Shanmuganathan S; Beets-Tan RGH; Aalbers AGJ; Lahaye MJ
    Br J Surg; 2019 Mar; 106(4):491-498. PubMed ID: 30353920
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center.
    Fava BEC; da Costa WL; Medeiros MLL; Sonagli M; de Castro Ribeiro HS; Diniz AL; Godoy AL; de Farias IC; de Jesus VHF; Begnami MDFS; Coimbra FJF
    World J Surg Oncol; 2018 Mar; 16(1):62. PubMed ID: 29566715
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer.
    Yonemura Y; Ishibashi H; Hirano M; Mizumoto A; Takeshita K; Noguchi K; Takao N; Ichinose M; Liu Y; Li Y
    Ann Surg Oncol; 2017 Feb; 24(2):478-485. PubMed ID: 27506661
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
    van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
    Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Waite K; Youssef H
    Ann Surg Oncol; 2017 Mar; 24(3):705-720. PubMed ID: 28058545
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020).
    Farrell R; Burling M; Lee YC; Pather S; Robledo K; Mercieca-Bebber R; Stockler M;
    J Gynecol Oncol; 2022 Jan; 33(1):e1. PubMed ID: 34783204
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
    Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
    Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
    Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
    Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
    Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.